Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 445Breast 198Other solid neoplasm 24Tumor-Agnostic 23Head & Neck 21Genitourinary 15CNS 13Thoracic 10Gynecologic 10Endocrine 5Sarcoma 3NET 3Dermatologic 3Lymphoid 2Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Other 1

Conditions

Obesity 1Neoplasms 1

Interventions

Exercise 15Metformin 14Surveys and Questionnaires 12Radiotherapy 9Methods 7naloxegol 6Nutrition Assessment 6Counseling 6alvimopan 5Resistance Training 5Psychiatric Rehabilitation 5Exenatide 5Early Intervention, Educational 5Diet Therapy 5Diet 5Sugars 4Mindfulness-Based Stress Reduction 4Injections 4Fibroblast Growth Factor 7 4Educational Status 4Drug Therapy 4Vitamin D 3Therapeutics 3Standard of Care 3Liraglutide 3Interviews as Topic 3Fentanyl 3Cryotherapy 3Cognitive Behavioral Therapy 3Cisplatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Capecitabine × Other × Clear all
NCT01828554 2019-11-25

Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight

University of Wisconsin, Madison

Phase NA Completed
8 enrolled 7 charts
Other

Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡